Literature DB >> 16159827

Extra-aortic balloon counterpulsation: an intraoperative feasibility study.

Malcolm E Legget1, William S Peters, F Paget Milsom, Judith S Clark, Teena M West, Renelle L French, Alan F Merry.   

Abstract

BACKGROUND: Current methods of counterpulsation or ventricular assistance have significant vascular and limb complications. The aim of this study was to determine the safety and performance of a new method of non-blood-contacting counterpulsation using an inflatable cuff around the ascending aorta (extra-aortic balloon [EAB]). METHODS AND
RESULTS: In 6 patients undergoing first time off-pump coronary bypass surgery via sternotomy, the EAB was secured around the ascending aorta and attached to a standard counterpulsation console. At baseline and with 1:2 and 1:1 augmentation, hemodynamic and echocardiographic parameters of ventricular function and coronary flow were measured. High-intensity transient signals were measured using transcutaneous Doppler over the right common carotid artery. No complications occurred. With EAB there was no significant change in heart rate or blood pressure and no increase in high-intensity transient signals. There was a 67% increase in diastolic coronary blood flow (mean left-main diastolic velocity time integral 15.3 cm unassisted versus 25.1 cm assisted, P<0.05). Measurements with transesophageal echocardiography at baseline and with 1:1 counterpulsation demonstrated a 6% reduction in end-diastolic area (P=NS), a 16% reduction in end-systolic area (P<0.01), a 31% reduction in left ventricular wall stress (P<0.05), and a 13% improvement in fractional area change (P<0.005).
CONCLUSIONS: EAB counterpulsation augments coronary flow and reduces left ventricular afterload. Further testing is warranted to assess the use of the EAB for chronic non-blood-contacting support of the failing heart.

Entities:  

Mesh:

Year:  2005        PMID: 16159827     DOI: 10.1161/CIRCULATIONAHA.104.521831

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies.

Authors:  Carlo R Bartoli; Robert D Dowling
Journal:  Cardiol Clin       Date:  2011-11       Impact factor: 2.213

Review 2.  Understanding the C-pulse device and its potential to treat heart failure.

Authors:  Virna L Sales; Patrick M McCarthy
Journal:  Curr Heart Fail Rep       Date:  2010-03

Review 3.  Aortic counterpulsation: C-pulse and other devices for cardiac support.

Authors:  Pallavi Solanki
Journal:  J Cardiovasc Transl Res       Date:  2014-02-20       Impact factor: 4.132

Review 4.  Miniaturization of mechanical circulatory support systems.

Authors:  Guruprasad A Giridharan; Thomas J Lee; Mickey Ising; Michael A Sobieski; Steven C Koenig; Laman A Gray; Mark S Slaughter
Journal:  Artif Organs       Date:  2012-08       Impact factor: 3.094

5.  Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function.

Authors:  Steven C Koenig; Kenneth N Litwak; Guruprasad A Giridharan; George M Pantalos; Robert D Dowling; Sumanth D Prabhu; Mark S Slaughter; Michael A Sobieski; Paul A Spence
Journal:  ASAIO J       Date:  2008 Nov-Dec       Impact factor: 2.872

6.  Muscle-Powered Counterpulsation for Untethered, Non-Blood-Contacting Cardiac Support: A Path to Destination Therapy.

Authors:  Jooli Han; Edgar Aranda-Michel; Dennis R Trumble
Journal:  IEEE Trans Biomed Eng       Date:  2020-02-18       Impact factor: 4.538

Review 7.  Evidence of clinical efficacy of counterpulsation therapy methods.

Authors:  M Capoccia; C T Bowles; J R Pepper; N R Banner; A R Simon
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

8.  Preliminary Results From the C-Pulse OPTIONS HF European Multicenter Post-Market Study.

Authors:  Antonia Schulz; Thomas Krabatsch; Jan D Schmitto; Roland Hetzer; Mirko Seidel; Pascal M Dohmen; Holger Hotz
Journal:  Med Sci Monit Basic Res       Date:  2016-02-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.